Aliskiren

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1203 publications

Baxdrostat (Baxfendy) - an aldosterone synthase inhibitor for hypertension.

Baxdrostat (Baxfendy) - an aldosterone synthase inhibitor for hypertension.

Journal: The Medical letter on drugs and therapeutics

Published: June 25, 2026

In brief: Widaplik - another three-drug combination for hypertension.

In brief: Widaplik - another three-drug combination for hypertension.

Journal: The Medical letter on drugs and therapeutics

Published: June 15, 2026

Renin-related changes after sequential switching from aliskiren to valsartan and sacubitril/valsartan in patients with a high-renin phenotype: a prospective pilot study.

Renin-related changes after sequential switching from aliskiren to valsartan and sacubitril/valsartan in patients with a high-renin phenotype: a prospective pilot study.

Journal: Clinical and experimental nephrology

Published: May 31, 2026

Integrated machine learning and structural bioinformatics guided identification of novel molecular scaffolds as renin inhibitors.

Integrated machine learning and structural bioinformatics guided identification of novel molecular scaffolds as renin inhibitors.

Journal: Molecular diversity

Published: February 20, 2026

Comparative Prognosis of Chagas and Other Cardiomyopathies.

Comparative Prognosis of Chagas and Other Cardiomyopathies.

Journal: Journal of the American College of Cardiology

Published: February 09, 2026

Retraction of: Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy.

Retraction of: Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy.

Journal: The Journal of pharmacy and pharmacology

Published: February 09, 2026

Combined RAS Modulation: The Effect on Plasma and Tissue Angiotensin Peptide Levels.

Combined RAS Modulation: The Effect on Plasma and Tissue Angiotensin Peptide Levels.

Journal: Physiological research

Published: January 14, 2026

A Real-World Disproportionality Analysis of Drug-Induced Heart Failure: Integrating FAERS Database and AHA Statement.

A Real-World Disproportionality Analysis of Drug-Induced Heart Failure: Integrating FAERS Database and AHA Statement.

Journal: Cardiovascular toxicology

Published: December 28, 2025

Choosing wisely in practice: How sick day rules help prevent medication-related complications.

Choosing wisely in practice: How sick day rules help prevent medication-related complications.

Journal: Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti

Published: December 18, 2025

Real-world safety of aliskiren in primary hypertension: A cross-database study.

Real-world safety of aliskiren in primary hypertension: A cross-database study.

Journal: PloS one

Published: December 06, 2025

Direct Renin Inhibition With Aliskiren Compared to Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Hypertension: A Systematic Review.

Direct Renin Inhibition With Aliskiren Compared to Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Hypertension: A Systematic Review.

Journal: Cureus

Published: November 13, 2025

From Peptides to Aliskiren: The Evolution of Direct Renin Inhibitors in Hypertension Therapy.

From Peptides to Aliskiren: The Evolution of Direct Renin Inhibitors in Hypertension Therapy.

Journal: Mini reviews in medicinal chemistry

Published: November 05, 2025

Showing 1-12 of 1,203

Last Updated: 09/26/2026